Investigating the role of a specific gene in Parkinson's disease.
Official title: The Role of GPNMB in Parkinson's Disease.
Funded at Albert Einstein College of Medicine · NIH-10981453 · Data updated 2026-11-12
This study is looking at how a specific gene might play a role in Parkinson's disease and related dementias, using advanced techniques to see how changes in this gene affect brain health, with the hope that it will lead to new treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | August 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $655,329 |
| NIH project number | 1R01NS133140-01A1 |
| Project ID | NIH-10981453 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Parkinson's disease, Lewy Body Dementia, or related neurodegenerative disorders.
✕Less likely to help
Patients with neurodegenerative diseases not related to Parkinson's or Lewy Body Dementia may not receive direct benefits from this research.
What this research studies
This research focuses on understanding how genetic factors, particularly the GPNMB gene, contribute to the development of Parkinson's disease and related dementias. By using advanced techniques like CRISPR/Cas9 in human stem cells, the study aims to explore how variations in this gene affect neuroinflammation and neurodegeneration. The researchers will analyze genetic data alongside epigenetic information to identify how these factors interact and influence disease progression. Patients may benefit from insights that could lead to new therapeutic strategies targeting these genetic pathways.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that specifically target the genetic factors involved in Parkinson's disease and related dementias.
How similar studies have gone: Previous research has shown promise in understanding genetic contributions to neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Soldner, Frank — Albert Einstein College of Medicine
- Study coordinator: Soldner, Frank
Related research
Other NIH-funded projects on the same topics.
-
Gut-brain clues in Parkinson’s disease: supplement to a large registry
A plant-wide supplement to an NIH program will enroll people with Parkinson’s, with and without GI symptoms, plus healthy controls, to study how gut function, brain signals, and sleep rhythms relate to Parkinson’s symptoms.
-
Gut-brain connections in Parkinson’s disease: how the gut and environment shape symptoms
A Mayo Clinic team is studying how gut problems, environmental factors, and genetics together influence Parkinson’s disease and its GI symptoms to find biomarkers and better understanding of the disease.
-
Gut-brain communication in Parkinson’s disease for better symptoms and daily life
This project enrolls people with Parkinson’s disease and healthy controls to build a big registry and study how gut function, brain signals, sleep, and circadian rhythms relate to PD symptoms.
-
Gut microbiome and Parkinson's disease: how gut bugs relate to symptoms and progression
A multi-year study will look at gut bacteria and related markers in people with Parkinson’s disease to understand how the gut-brain connection may influence symptoms and progression.
-
Gut-Brain Axis in Parkinson’s Disease: biomarkers and procedures to track progression
A patient-focused program to study how gut health and the brain interact in Parkinson’s disease using biomarkers and clinical procedures.
-
Understanding posture and movement in Parkinson’s patients to reduce falls
A study using wearable sensors to track real-world balance and movement in people with Parkinson’s disease to help prevent falls.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.